ArticleCancers2022

Modulation of the Tumor Microenvironment with Trastuzumab Enables Radiosensitization in HER2+ Breast Cancer.

Patrick N Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.